Replies to post #69832 on NanoViricides Inc. (NNVC)

[Puffer]

that all looks good based on what we currently know. I figure Q3 for start of human trials just to be slightly more conservative.

Although they have the ability to go it alone, I think there is a fairly good chance they strike a deal with big pharma on completion of Phase I/IIa which would allow them to start funding the rest of the big drugs in their pipeline. That could also come before the end of next year. I would have to think a deal price at that juncture would be in the range of a couple billion (upfront and milestones) plus royalties on a successful drug. We would be looking all grown up in fairly short order. Not that far away...